InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Thursday, 03/25/2021 12:55:52 AM

Thursday, March 25, 2021 12:55:52 AM

Post# of 14953
I was asked if I had confidence in Sorrento's Covid portfolio. We should soon hear about the rapid accurate tests. Meanwhile I expect near-term news about both Abivertinib and Covi-MSC progress. I have great confidence in the 3 forms of 2020. And I look forward to news about the pan-variant antibody cocktail.

I was very pleased to hear that Sorrento now owns 100% of Scilex. It will be a real cash cow with SP-102 and RTX approvals and ARD-301 for long haulers could be big.

And Abivertinib , ADNAB, plasmid DNA and Dar-T in dozens of cancer applications have oustanding potential. These are all first-in-class and best-in-class IMO.

But I must admit I am amazed by the Celularity and ImmunityBio investment potential. And if there's any justice in this world PSS will soon be handing over $1+ billions to Sorrento. I've never before invested in such a well funded...wide portfolio...small biotech!


"The refusal of the real is the number one dogma of our time" Rene Girard